DrugPatentWatch Database Preview
Details for Patent: 10,213,400
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 10,213,400 protect, and when does it expire?
Patent 10,213,400 protects XYREM and is included in one NDA.
This patent has twenty-one patent family members in eighteen countries.
Summary for Patent: 10,213,400
| Title: | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| Abstract: | One embodiment of the present invention is to improve the safety and efficacy of the administration of GHB or a salt thereof to a patient. It has been discovered that the concomitant administration of an MCT inhibitor, such as diclofenac, valproate, or ibuprofen, will affect GHB administration. For example, it has been discovered that diclofenac lowers the effect of GHB in the body, thereby potentially causing an unsafe condition. Furthermore, it has been discovered that valproate increases the effect of GHB on the body, thereby potentially causing an unsafe condition. |
| Inventor(s): | Eller; Mark (Redwood City, CA) |
| Assignee: | JAZZ PHARMACEUTICALS IRELAND LIMITED (Dublin, IE) |
| Application Number: | 15/869,792 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,213,400
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms | XYREM | sodium oxybate | SOLUTION;ORAL | 021196-001 | Jul 17, 2002 | AA | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF REDUCING ADVERSE EFFECTS IN PATIENTS SUFFERING FROM EXCESSIVE DAYTIME SLEEPINESS AND/OR CATAPLEXY IN NARCOLEPSY WHO ARE CONCOMITANTLY ADMINISTERED SODIUM OXYBATE AND DIVALPROEX SODIUM | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,213,400
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014223373 | Start Trial | |||
| Brazil | 112015021012 | Start Trial | |||
| Canada | 2902948 | Start Trial | |||
| China | 105073106 | Start Trial | |||
| Cyprus | 1120086 | Start Trial | |||
| Denmark | 2961399 | Start Trial | |||
| European Patent Office | 2961399 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
